Navigation Links
Molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves

Weizmann Institute findings might advance search for new therapies for injured nerve fibers. Long distance messengers star in many heroic tales, perhaps the most famous being the one about the runner who carried the news about the victory of the Greeks over the Persians in the fateful battle of Marathon. A team of researchers at the Weizmann Institute of Science has now discovered how molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves.

A nerve cell has a cell body and a long extension, called an axon, which in humans can reach up to one meter in length. Nerve cells belonging to the peripheral nervous system can regrow when their axons are damaged. But how does the damaged axon inform the cell body that it must start producing vital proteins for the healing? That's precisely where the molecular messengers, proteins called Erk-1 and Erk-2, enter the picture. When the axon is injured, these proteins bind to molecules of phosphorus. In this phosphorylated state, they can communicate to command centers in the cell, transmitting a message that activates certain genes in the cell body, which then manufactures proteins that are vital for the healing of the injured axon. The problem is that the messengers must transmit their phosphorus message over a great distance along the axon, and in the course of this arduous journey can easily lose their phosphorus en route.

Dr. Michael Fainzilber and graduate students Eran Perlson and Shlomit Hanz of the Weizmann Institute's Biological Chemistry Department found that the Erk messengers, together with their phosphorus message, bind to a special molecule called vimentin, which protects them from dismantling or loss of the phosphorus. Vimentin links up to motor proteins that carry the message along the axon, and thanks to this linkage and protection, the messengers can safely transmit their message, thus bringing the injured axon's call for help to the cell body. The study will be published in the March 3'rd issue of Neuron. The scientists hope that these findings might advance the future search for new therapies for injured nerve fibers.


The research team also included Prof. Rony Seger of the Biological Regulation Department, Prof. Michael Elbaum of the Materials and Interfaces Department, graduate students Keren Ben Yaakov and Yael Segal-Ruder of the Biological Chemistry Department, and postdoctoral fellow Dr. Daphna Frenkiel-Krispin of the Materials and Interfaces Department.

Dr. Michael Fainzilber's research is supported by the Y. Leon Benoziyo Institute for Molecular Medicine; Mr. and Mrs. Alan Fischer, Larchmont, NY; the Abisch Frenkel Foundation for the Promotion of Life Sciences; the Irwin Green Alzheimer's Research Fund and the Buddy Taub Foundation.

Dr. Fainzilber is the incumbent of the Daniel E. Koshland Sr. Career Development Chair.


Source:Weizmann Institute

Related biology news :

1. Molecular biology fills gaps in knowledge of bat evolution
2. Molecular machine may lead to new drugs to combat human diseases
3. Molecular Motors Cooperate In Moving Cellular Cargo, Study Shows
4. Molecular models advance the fight against malaria
5. Molecular fossils uncover link between viruses and the immune system
6. Molecular thermometers on skin cells detect heat and camphor
7. Molecular steps involved in the creation of gene-silencing microRNAs identified
8. Molecular miners find pain relief drugs from the sea
9. Molecular mechanism of feather formation found
10. Molecular trigger for Huntingtons disease found
11. Molecular Partners Required For Appropriate Neuronal Gene Repression
Post Your Comments:

(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology: